GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nanobac Pharmaceuticals NNBP · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2007

Revenue

$17,621

FY2007FY2007

Net income

−$6.6m

FY2007FY2007

Free cash flow

−$912,419

FY2007FY2007

Shareholders' equity

−$2.4m

FY2007FY2007

Income statement

Fiscal years

FY2007
Revenue$17,621
Gross profit$3,102
Research and development$1.1m
Operating income−$4.4m
Net income−$6.6m
Diluted earnings per share-0.74

Balance sheet

At each fiscal year end

FY2007
Total assets$7.2m
Total liabilities$9.6m
Debt$4.1m
Shareholders' equity−$2.4m
Shares outstanding9m

Cash flow

Fiscal years

FY2007
Cash from operations−$910,886
Capital spending−$1,533
Free cash flow−$912,419

Latest quarters

By quarter end

Dec 2007Sept 2007Jun 2007Mar 2007Dec 2006Sept 2006Jun 2006Mar 2006
Revenue$4,368$5,809$2,432$5,012$2,000$24,000$38,000$161,000
Gross profit$678$1,142$530$752————
Operating income−$661,407−$535,483−$679,387−$2.6m————
Net income−$1.2m−$835,763−$716,562−$3.9m————
Diluted earnings per share-0.13-0.09-0.08-0.43————
Total assets$7.2m$7.3m$7.5m$7.6m$7.8m$8.1m$8.2m$8.8m
Debt$4.1m$3.9m$3.6m$3.3m————
Shareholders' equity−$2.4m−$2.2m−$1.1m−$345,050——$256,000$1.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-63.4%8.0%-44.4%
Operating income-16.4%—18.8%
Net income-8.3%—22.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin61.1%66.3%56.6%42.9%
Operating margin-3569.5%-1518.6%——
Net margin-4758.6%-1888.5%——

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%0%0%92129%1804175%23154%18018%62900%209355%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.